DarioHealth
NEW YORK, New York, United States · Biotechnology, Fitness, Health Care
DarioHealth Corp. (NASDAQ:DRIO) Dario is changing the way people manage their health, with consumer-friendly digital solutions proven to power lasting behavior change. Dario integrates comprehensive support across a wide range of common and connected health needs, from well-being to chronic condition management, to help our members find long-term success. Billions of data insights from a decade of
Key facts
- Headquarters
- NEW YORK, New York, United States
- Employees
- 170
- Industries
- Biotechnology, Fitness, Health Care
- Status
- Public (DRIO)
- Website
- www.dariohealth.com
- Company page
Recent activity at DarioHealth
- : SEC 8-K (5.02): On September 2, 2026, Lawrence Leisure notified the Board of Directors of DarioHealth Corp. of his decision to retire from the Board, effective immediately. His retirement was not due to any disagreement with the Company regarding its operations or policies. There are no financial implications mentioned related to this change in the Board's composition, and it marks a significant shift in the governance of the company.
- : DarioHealth Announces Separation Agreement with President Steven Nelson
- : SEC 8-K (5.02): On August 20, 2026, DarioHealth Corp. entered into a Separation Agreement with Steven Nelson, who will cease to serve as the President and Chief Commercial Officer effective September 1, 2026, with his employment ending on September 30, 2026. The agreement stipulates that Mr. Nelson will receive all earned wages along with accrued and unused vacation time, and his health insurance coverage will remain in effect until his separation date. This decision follows the extension of Mr. Nelson's medical leave initiated on July 10, 2026, indicating potential challenges within the company's leadership continuity. The strategic implications of this departure could impact the company's operations and direction in the market.
- : DarioHealth Corp. secures $23.5 million in a registered direct offering of common stock. The financing was led by existing institutional investors and a new global investor.
- : SEC 8-K (1.01): On July 22, 2026, DarioHealth Corp. entered into a Securities Purchase Agreement, agreeing to issue and sell an aggregate of 2,437,060 shares of its common stock and pre-funded warrants to purchase an aggregate of 1,017,499 shares. The shares are priced at $6.80 each, with the total expected gross proceeds from this registered direct offering being approximately $23.5 million. Additionally, Dennis Matheis, a board member, has agreed to purchase 14,430 shares at $6.93 per share. The offering is anticipated to close on or about July 23, 2026, subject to customary conditions. The terms also include a 30-day restriction on issuing further shares post-closing, with certain exceptions for existing agreements.
- : SEC 8-K (1.01): On July 22, 2026, DarioHealth Corp. entered into a Securities Purchase Agreement with institutional investors to conduct a registered direct offering. The Company agreed to issue 2,437,060 shares of common stock at $6.80 per share and pre-funded warrants to purchase 1,017,499 shares at an offering price of $6.7999. The offering is expected to generate approximately $23.5 million in gross proceeds before expenses. This agreement is a significant step for the Company in raising capital for its operations and growth initiatives.
- : DarioHealth Secures $23.5 Million in Direct Offering
- : DarioHealth Corp. Appoints Interim Management During Leadership Absence
- : SEC 8-K (5.02): On July 10, 2026, DarioHealth Corp. announced the extension of Steven Nelson's temporary medical leave of absence as President and Chief Commercial Officer for an indefinite period. During his absence, his responsibilities will be managed by other senior management team members. This change indicates potential restructuring within the company’s leadership, which may impact decision-making processes and strategic direction moving forward.
- : SEC 8-K (5.02): On July 10, 2026, Steven Nelson, the President and Chief Commercial Officer of DarioHealth Corp., was granted an indefinite extension of his temporary medical leave of absence. During this period, his responsibilities will be managed by other senior management team members, indicating a significant operational shift within the company. This leadership gap may affect decision-making processes and company strategy until Mr. Nelson returns. The filing emphasizes the company's adaptability in leadership during unforeseen circumstances in its key management.
DarioHealth funding history
| Date | Round | Amount |
|---|---|---|
| Jul 2026 | Post-IPO Equity | $23.5M |
| Oct 2025 | Venture | $17.5M |
| May 2025 | Debt Financing | $32.5M |
| Jan 2025 | Venture | $18.8M |
| Jan 2025 | Venture | $6.8M |
Leadership
- Erez Raphael, Executive Officer, Director
- Yoav Shaked, Director
- Adam Stern, Director
- Dennis Matheis, Director
- Hila Karah, Director
- Dennis McGrath, Director
- Richard Stone, Director
Verified email and direct lines for DarioHealth’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
DarioHealth files 3 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
DarioHealth in the news
- Vulnerabilities Identified in Dario Health’s Blood Glucose Monitoring Android App - The HIPAA Journal (Mar 04, 2025)
- DarioHealth partners with Medicare Advantage plan for digital mental health benefits - MobiHealthNews (Oct 02, 2024)
- DarioHealth to Report Third Quarter 2026 Results on Thursday, November 12, 2026 - TradingView (Nov 02, 2026)
- Sanofi’s Felix Lee talks DarioHealth partnership, future of digital health - MedTech Dive (Jul 21, 2023)
- Dario Announces Strategic Collaboration with Beluga Health to Deliver Provider-Backed, Integrated Care at Scale - PR Newswire (Jun 29, 2026)
- DarioHealth Corp. (DRIO) stock price, news, quote and history - Yahoo Finance UK (May 18, 2017)
- About 2.5× Higher Costs for Untreated Sleep Apnea; Dario Launches Care - Stock Titan (Aug 04, 2026)
- DarioHealth launches MSK platform Dario Move - MobiHealthNews (Oct 19, 2021)
Companies similar to DarioHealth
- StuffThatWorks · Biotechnology, Fitness, Health Care, Wellness
- Tolion Health · Biotechnology, Fitness, Health Care, Wellness
- Sault Ste. Marie YMCA · Fitness, Health Care, Wellness
- Pvolve · Fitness, Health Care, Wellness
- MuscleBlaze · Fitness, Health Care, Wellness
About DarioHealth: questions and answers
What does DarioHealth do?
DarioHealth Corp. (NASDAQ:DRIO) Dario is changing the way people manage their health, with consumer-friendly digital solutions proven to power lasting behavior change. Dario integrates comprehensive support across a wide range of common and connected health needs, from well-being to chronic condition management, to help our members find long-term success. Billions of data insights from a decade of
Where is DarioHealth headquartered?
DarioHealth is headquartered in NEW YORK, New York, United States.
How many employees does DarioHealth have?
DarioHealth has about 170 employees.
Has DarioHealth raised funding?
Yes. Fundz has recorded 5 funding events for DarioHealth. The most recent, Post-IPO Equity of $23.5M, was in Jul 2026.
What is the latest news on DarioHealth?
On Sep 02, 2026, SEC 8-K (5.02): On September 2, 2026, Lawrence Leisure notified the Board of Directors of DarioHealth Corp. of his decision to retire from the Board, effective immediately. His retirement was not due to any disagreement with the Company regarding its operations or policies. There are no financial im
Is DarioHealth a public company?
Yes. DarioHealth is publicly traded under the ticker DRIO.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy